Kyle Gano
Director, Chief Executive Officer · 4 filings · Latest: Sep 11, 2026
NEUROCRINE BIOSCIENCES INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBIX | Kyle Gano | Director, Chief Executive Officer | Feb 13, 2026 | Option Exercise | $0.00 | 4,807 | — | 147,610 | |
NBIX | Kyle Gano | Director, Chief Executive Officer | Feb 12, 2026 | Option Exercise | $0.00 | 4,907 | — | 146,661 | |
NBIX | Kyle Gano | Director, Chief Executive Officer | Jan 31, 2026 | Option Exercise | $0.00 | 2,927 | — | 143,334 | |
NBIX | Kyle Gano | Director, Chief Executive Officer | Jan 16, 2026 | Sale | $132.70 | 36,400 | $4.8M | 140,407 | |
NBIX | Kyle Gano | Director, Chief Executive Officer | Jan 16, 2026 | Option Exercise | $35.99 | 36,400 | $1.3M | 142,219 | |
NBIX | KYLE GANO | — | Jan 16, 2026 | Proposed Sale | $133.35 | 36,400 | $4.9M | — | |
NBIX | Gano Kyle | — | Nov 4, 2025 | Proposed Sale | $141.97 | 300 | $42.6K | — | |
NBIX | KYLE W GANO | — | Feb 13, 2025 | Proposed Sale | $117.18 | 1,206 | $141.3K | — | |
NBIX | KYLE GANO | — | Feb 13, 2025 | Proposed Sale | $117.18 | 1,352 | $158.4K | — | |
NBIX | KYLE W GANO | — | Feb 10, 2025 | Proposed Sale | $122.62 | 980 | $120.2K | — | |
NBIX | KYLE GANO | — | Jan 31, 2025 | Proposed Sale | $153.29 | 1,541 | $236.2K | — | |
NBIX | KYLE W GANO | — | Jan 15, 2025 | Proposed Sale | $139.51 | 65,000 | $9.1M | — |